Biology of somatostatin in breast cancer

Mol Cell Endocrinol. 2008 May 14;286(1-2):251-61. doi: 10.1016/j.mce.2008.01.006. Epub 2008 Jan 20.

Abstract

The biological effects of the neuropeptide somatostatin (SST) are mediated via a family of five somatostatin receptors (SSTRs) belonging to a family of G-protein-coupled receptors (GPCRs). SSTR regulate the secretion of hormones, growth factors, neurotransmission and cell growth in receptor-specific manner. In addition, SST plays an inhibitory role in several mammary cancer models. These effects are mediated both indirectly through inhibition of hormones and growth factors which promote tumor growth as well as directly via SSTRs present on tumor cells to inhibit mitogenic signaling of growth factor receptor kinases leading to growth arrest and induction of apoptosis. Here, we present an overview on the role of SST and its analogs in breast cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Sequence
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Female
  • Humans
  • Molecular Sequence Data
  • Receptors, Somatostatin / agonists
  • Receptors, Somatostatin / physiology*
  • Signal Transduction
  • Somatostatin / analogs & derivatives
  • Somatostatin / physiology*
  • Somatostatin / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Receptors, Somatostatin
  • Somatostatin